Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Estimated Market Size of the Gastroparesis Drugs Market In 2029?#_x000D_

The market size for gastroparesis medications has seen substantial growth in recent times. The market is projected to expand from a value of $5.39 billion in 2024 to around $5.7 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.7%. This growth in the past period is a result of various factors including the side effects of current treatments, research into gastrointestinal motility, clinical demand, the push from patient advocacy groups, and regulatory backing._x000D_

_x000D_

Anticipated to witness substantial growth in the coming years, the market size of gastroparesis drugs is projected to reach $7.04 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. Factors leading to growth during this forecast period include escalating incidences of diabetes, an ageing demographic, heightened awareness and diagnosis, growth in healthcare spending, alongside government and private sector funding. The forecast period will also see significant trends such as progress in the field of gastroenterology, enhancements in diagnostic methodologies, technological innovation, backed by research investment and joint research endeavours._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15812&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theGastroparesis Drugs Market?#_x000D_

Gastroparesis drug market growth is expected to be fueled by the increasing cases of diabetes. High blood sugar levels due to either insufficient insulin production or insulin’s ineffective utilization are the highlights of this ongoing health crisis named diabetes. The surge in diabetes cases is a result of inactive lifestyles, unhealthy eating habits, genetic factors, urbanization, and aging population. This is further intensified by inadequate healthcare and the growing global obesity figures. It’s common practice for doctors to prescribe gastroparesis medications for diabetics experiencing symptoms such as nausea, vomiting, and delayed gastric emptying; all are typical complications of diabetes affecting the gastrointestinal movement. The goal of these drugs is to boost gastric function, thereby improving the quality of life for those suffering from diabetes-induced gastroparesis. As an example, the Office for Health Improvement & Disparities, a government department based in the UK, reported in March 2024 that from March 2022 to March 2023, there was a 22% increase in the number of people with type 1 diabetes who were undergoing all eight recommended care processes. This figure was 21% for type 2 diabetes, while those accomplishing the target HbA1c levels increased to the highest-ever reported figure of 37.9%, as per the National Diabetes Audit (NDA). Consequently, the escalating cases of diabetes are pushing the growth of the gastroparesis drugs market._x000D_

_x000D_

#What Segment Types Define the Gastroparesis Drugs Market Structure?#_x000D_

The gastroparesis drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Over-the-counter (OTC) Drugs, Prescription Drugs_x000D_

2) By Drug Class: Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes_x000D_

3) By Disease Type: Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types_x000D_

4) By Route Of Administration: Oral, Injectables, Other Routes Of Administration_x000D_

5) By Distribution Channel: Hospitals, Pharmacies, Clinics, E-commerce_x000D_

_x000D_

Subsegments:_x000D_

1) Over-the-counter (OTC) Drugs: Antacids, Anti-Nausea Medications, Antiemetics, Digestive Enzyme Supplements_x000D_

2) Prescription Drugs: Prokinetic Agents, Antiemetic Drugs, Antibiotics, Antidepressants_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15812&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Gastroparesis Drugs Market?#_x000D_

North America was the largest region in the gastroparesis drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroparesis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Gastroparesis Drugs Market?#_x000D_

Companies that are leading in the gastroparesis drugs market are prioritizing the development and introduction of novel medications, such as Gimoti (metoclopramide) nasal spray, in order to gain a strategic advantage. Gimoti (metoclopramide) nasal spray is a therapeutic drug used for treating gastroparesis symptoms in adults by enhancing the gastric emptying process through improved gastrointestinal function. The drug bypasses the gastrointestinal system and enters the bloodstream directly through the nasal mucosa. For example, in April 2022, Evoke Pharma Inc., an American pharmaceutical firm, reported that the U.S. Food and Drug Administration (FDA) had bestowed new drug product exclusivity to GIMOTI (metoclopramide) nasal spray. This is exclusive marketing rights for three years starting from the approval date as per the Hatch-Waxman Act, safeguarding the product from any generic competition._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report_x000D_

_x000D_

#What Is the Definition of the Gastroparesis Drugs Market?#_x000D_

Gastroparesis drugs are medications used to manage and treat gastroparesis, a condition where the stomach’s ability to empty its contents is delayed, causing symptoms such as nausea, vomiting, and abdominal pain. These drugs typically include prokinetics to stimulate stomach motility, antiemetics to control nausea and vomiting, and medications to manage pain and other symptoms associated with the condition._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15812_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model